Cubist Systematic Strategies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$428K Buy
+162,785
New +$359K ﹤0.01% 2351
2025
Q2
Sell
-194,031
Closed -$213K 3181
2025
Q1
$213K Buy
+194,031
New +$224K ﹤0.01% 2496
2024
Q2
Sell
-140,083
Closed -$165K 3375
2024
Q1
$165K Buy
+140,083
New +$154K ﹤0.01% 3149
2023
Q3
Sell
-112,798
Closed -$135K 3562
2023
Q2
$135K Sell
112,798
-136,514
-55% -$170K ﹤0.01% 2925
2023
Q1
$314K Buy
249,312
+85,913
+53% +$164K ﹤0.01% 2965
2022
Q4
$355K Sell
163,399
-348,392
-68% -$2.87M ﹤0.01% 3255
2022
Q3
$6.13M Buy
511,791
+447,095
+691% +$5.55M 0.03% 880
2022
Q2
$542K Sell
64,696
-31,566
-33% -$245K ﹤0.01% 3000
2022
Q1
$836K Buy
96,262
+39,304
+69% +$379K 0.01% 2177
2021
Q4
$644K Sell
56,958
-18,060
-24% -$215K 0.01% 2258
2021
Q3
$943K Buy
75,018
+60,922
+432% +$561K 0.01% 1568
2021
Q2
$114K Sell
14,096
-28,958
-67% -$251K ﹤0.01% 2702
2021
Q1
$398K Buy
43,054
+27,289
+173% +$275K 0.01% 2086
2020
Q4
$152K Sell
15,765
-32,932
-68% -$324K ﹤0.01% 2332
2020
Q3
$604K Buy
48,697
+9,609
+25% +$127K 0.01% 1631
2020
Q2
$508K Buy
+39,088
New +$492K 0.01% 1582

Other funds holding GOSS

Cubist Systematic Strategies's GOSS Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Gossamer Bio (GOSS) in Q3 2025: 162,785 shares worth $428K. The stake represents ﹤0.01% of the portfolio and ranks #2351 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in GOSS as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in GOSS in Q2 2020 and has held it in 16 quarters since. The position peaked at $6.13M in Q3 2022. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Cubist Systematic Strategies held 162,785 shares of Gossamer Bio worth $428K as of Q3 2025.
  • Gossamer Bio was a new Cubist Systematic Strategies position in Q3 2025.
  • Gossamer Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2351 holding.
  • Cubist Systematic Strategies first reported a position in Gossamer Bio in Q2 2020 and has held it in 16 quarters since.
  • Cubist Systematic Strategies's Gossamer Bio position peaked at $6.13M in Q3 2022.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.